Technical Analysis for NNVC - NanoViricides, Inc.

Grade Last Price % Change Price Change
B 5.08 -3.05% -0.16
NNVC closed down 3.05 percent on Friday, September 24, 2021, on 31 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NNVC trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Calm After Storm Range Contraction -3.05%
Wide Bands Range Expansion -3.05%
Jack-in-the-Box Bullish Bullish Swing Setup -11.65%
Calm After Storm Range Contraction -11.65%
Parabolic Rise Strength -11.65%
Older End-of-Day Signals for NNVC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 16 hours ago
Down 3% about 19 hours ago
Up 3% about 19 hours ago
Down 2 % about 19 hours ago
Down 1% about 19 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NanoViricides, Inc. Description

NanoViricides, Inc. a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, a injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could enable a functional cure for HIV/AIDS; HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; Nanoviricide anti-viral eye drops against external eye viral infections; and DengueCide, a treatment against Dengue viruses. It is also developing RabiCide, an anti-rabies nanoviricide; and Nanoviricide for the treatment of various strains of Ebola and Marburg filoviruses. The company has licenses to develop drugs for the treatment of human viral diseases, such as H5N1 (avian flu), human influenza, human immunodeficiency virus (HIV/AIDS), hepatitis B virus, hepatitis C virus, herpes simplex virus, and rabies; and dengue viruses, Japanese encephalitis virus, West Nile virus, viruses causing viral conjunctivitis and ocular herpes, and Ebola/Marburg viruses, as well as viral diseases of the eye comprising epidemic kerato-conjunctivitis and herpes keratitis. NanoViricides, Inc. was founded in 2005 and is based in West Haven, Connecticut.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Eye Infectious Diseases Infection Influenza Coronavirus Hepatitis B Viruses HIV Hepatitis C Immunodeficiency Hepatitis B Virus Hepatitis C Virus Herpes HIV/Aids Antiviral Drug Viral Disease Virus Herpes Simplex Rabies Viral Diseases Herpes Simplex Virus Ebola Viral Infection Viral Infections Dengue Epidemiology Genital Herpes Human Influenza Viral Conjunctivitis

Is NNVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.71
52 Week Low 2.85
Average Volume 3,355,640
200-Day Moving Average 4.17
50-Day Moving Average 4.13
20-Day Moving Average 4.34
10-Day Moving Average 4.73
Average True Range 0.63
ADX 39.49
+DI 44.74
-DI 10.46
Chandelier Exit (Long, 3 ATRs) 5.98
Chandelier Exit (Short, 3 ATRs) 5.62
Upper Bollinger Bands 5.69
Lower Bollinger Band 2.98
Percent B (%b) 0.77
BandWidth 62.42
MACD Line 0.34
MACD Signal Line 0.20
MACD Histogram 0.1398
Fundamentals Value
Market Cap 54.18 Million
Num Shares 10.7 Million
EPS -2.40
Price-to-Earnings (P/E) Ratio -2.12
Price-to-Sales 0.00
Price-to-Book 1.32
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.76
Resistance 3 (R3) 5.80 5.63 5.64
Resistance 2 (R2) 5.63 5.45 5.60 5.60
Resistance 1 (R1) 5.35 5.35 5.27 5.31 5.57
Pivot Point 5.18 5.18 5.13 5.15 5.18
Support 1 (S1) 4.90 5.00 4.82 4.86 4.59
Support 2 (S2) 4.73 4.90 4.70 4.56
Support 3 (S3) 4.45 4.73 4.52
Support 4 (S4) 4.41